291 related articles for article (PubMed ID: 7636731)
21. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
22. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
23. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
[TBL] [Abstract][Full Text] [Related]
26. Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice.
Shook JE; Dewey WL
J Pharmacol Exp Ther; 1986 Jun; 237(3):841-7. PubMed ID: 3712281
[TBL] [Abstract][Full Text] [Related]
27. Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Brain Res; 1993 Aug; 619(1-2):163-72. PubMed ID: 8374774
[TBL] [Abstract][Full Text] [Related]
28. Cellular mechanisms of opioid tolerance: studies in single brain neurons.
Christie MJ; Williams JT; North RA
Mol Pharmacol; 1987 Nov; 32(5):633-8. PubMed ID: 2824980
[TBL] [Abstract][Full Text] [Related]
29. A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent mice.
Shook JE; Pelton JT; Kazmierski W; Lemcke PK; Villar RG; Hruby VJ; Burks TF
NIDA Res Monogr; 1987; 76():295-301. PubMed ID: 2893981
[TBL] [Abstract][Full Text] [Related]
30. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
31. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
Kamei J; Kawashima N; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
Psychopharmacology (Berl); 1993; 113(2):167-71. PubMed ID: 7855177
[TBL] [Abstract][Full Text] [Related]
32. Effects of diabetes on the morphine-induced Straub tail reaction in mice.
Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Aug; 178(1):66-8. PubMed ID: 7816343
[TBL] [Abstract][Full Text] [Related]
33. Possible involvement of mu 2-mediated mechanisms in mu-mediated antitussive activity in the mouse.
Kamei J; Iwamoto Y; Kawashima N; Suzuki T; Nagase H; Misawa M; Kasuya Y
Neurosci Lett; 1993 Jan; 149(2):169-72. PubMed ID: 8386345
[TBL] [Abstract][Full Text] [Related]
34. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
[TBL] [Abstract][Full Text] [Related]
35. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
DeLander GE; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1984 Oct; 231(1):91-6. PubMed ID: 6092607
[TBL] [Abstract][Full Text] [Related]
36. The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse.
Suzuki T; Hayashi Y; Misawa M
Life Sci; 1992; 50(12):849-56. PubMed ID: 1312192
[TBL] [Abstract][Full Text] [Related]
37. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
Gmerek DE; Woods JH
J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
Abdelhamid EE; Takemori AE
Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
[TBL] [Abstract][Full Text] [Related]
39. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
Smits SE
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
